THERAPEUTIC EFFECT OF INDUCTION OF POLYGLUTAMYLATION IN HIGH-DOSE METHOTREXATE THERAPY TO PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

被引：0
|
作者：
Fujimoto, Kenji [1 ]
Shinojima, Naoki [1 ]
Makino, Keishi [1 ]
Ichimura, Koichi [2 ]
Mukasa, Akitake [1 ]
机构：
[1] Kumamoto Univ, Dept Neurosurg, Kumamoto, Japan
[2] Natl Canc Ctr, Div Brain Tumor Translat Res, Res Inst, Chuo Ku, Tokyo, Japan
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CBMT-09
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] Tirabrutinib maintenance therapy for a patient with high-dose methotrexate-ineligible primary central nervous system lymphoma
    Tadashi Okamura
    Hiroki Hosoi
    Takeshi Matsufusa
    Yuina Akagi
    Ryuta Iwamoto
    Hideki Kosako
    Shogo Murata
    Toshiki Mushino
    Shin-Ichi Murata
    Takashi Sonoki
    [J]. Annals of Hematology, 2022, 101 : 1379 - 1381
  • [22] What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?
    Dalia, Samir
    Price, Samantha
    Forsyth, Peter
    Sokol, Lubomir
    Jaglal, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 500 - 502
  • [23] Treatment of relapsed central nervous system lymphoma with high-dose methotrexate
    Plotkin, SR
    Betensky, RA
    Hochberg, FH
    Grossman, SA
    Lesser, GJ
    Nabors, LB
    Chon, B
    Batchelor, TT
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5643 - 5646
  • [24] High-dose methotrexate for elderly patients with newly diagnosed primary central nervous system lymphoma
    Zhu, J
    Mrugala, M
    Nugent, W
    Hochberg, F
    Batchelor, T
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 124 - 124
  • [25] Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
    Bergner, Nicole
    Monsef, Ina
    Illerhaus, Gerald
    Engert, Andreas
    Skoetz, Nicole
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [26] Stereotactic radiosurgery in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma
    Long, H.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 36 - 36
  • [27] Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma
    Joerger, M.
    Huitema, A. D. R.
    Illerhaus, G.
    Ferreri, A. J. M.
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1867 - 1875
  • [28] SUCCESSFUL TREATMENT OF RECURRENT PRIMARY CENTRAL NERVOUS-SYSTEM LYMPHOMA WITH HIGH-DOSE METHOTREXATE
    ERVIN, T
    CANELLOS, GP
    [J]. CANCER, 1980, 45 (07) : 1556 - 1557
  • [29] PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: HIGH-DOSE METHOTREXATE PLUS RADIOTHERAPY, BETTER TREATMENT FOR ALL?
    Gonzalez-Domingo, M.
    Gonzalez-San Segundo, C.
    Menarguez, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S361 - S362
  • [30] Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphoma
    Sun, Kai
    Tao, Hongwei
    Ding, Tianling
    Li, Ziran
    Qiu, Xiaoyan
    Zhong, Mingkang
    Wu, Zhuo
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (12) : 2196 - 2204
12345